New Weight-Loss Drug Offers Key Advantage Over Ozempic
Eli Lilly's new weekly injection eloralintide shows 20.1% weight loss while preserving muscle mass. Discover this promising alternative to GLP-1 drugs and new affordable pricing.
Category : Pharmaceuticals
Drug Exec Faints at Trump's Oval Office Press Conference
A pharmaceutical executive fainted during a Trump press conference on weight-loss drugs. Dr Oz intervened and shares essential first aid advice for such emergencies. Read the full story.
Trump's Weight Loss Sparks Pharmaceutical Frenzy
Donald Trump's dramatic weight loss sparks pharmaceutical frenzy as Novo Nordisk faces unprecedented demand for revolutionary diabetes medications.
Trump slams 'fat shot' weight loss drugs in explosive rant
Donald Trump launches astonishing attack on revolutionary weight-loss injections like Wegovy and Ozempic, branding them the 'fat shot' while claiming natural methods are superior. The former president's controversial health comments spark medical debate.
Trump's plan to slash weight-loss drug prices
Former President Donald Trump proposes dramatic government intervention to cut costs of blockbuster drugs like Ozempic and Wegovy, challenging pharmaceutical giants and reshaping US healthcare policy.
Novo Nordisk exec fatally stabbed in Connecticut rampage
A Novo Nordisk executive was brutally stabbed to death in a random attack outside a Connecticut grocery store, while his wife miraculously survived the same frenzied assault that left multiple victims.
Trump pledges to cut weight-loss drug prices
Former President Donald Trump vows to dramatically reduce prices of GLP-1 medications including Ozempic and Wegovy if re-elected, targeting pharmaceutical giants in latest healthcare pledge.
NHS patients may get only generic drugs, warns AstraZeneca
The CEO of pharmaceutical giant AstraZeneca warns that NHS patients may be limited to generic medicines unless the health service increases what it pays for branded drugs, raising concerns about access to cutting-edge treatments.
FDA Warns of Dangerous Counterfeit Botox Products
US health authorities sound alarm over counterfeit Botox injections linked to severe illnesses. Essential safety information for British patients considering cosmetic treatments.
Trump Pressures Novo Nordisk Over Ozempic Pricing
Former President Donald Trump is reportedly pushing pharmaceutical giant Novo Nordisk for major Ozempic price cuts in a move that could transform diabetes and weight loss treatment accessibility in America.
Morning After Pill May Combat Cancer Cells
Groundbreaking research reveals the morning after pill's unexpected potential in cancer prevention, with scientists discovering levonorgestrel's ability to combat deadly diseases.
Weight Loss Drug Showdown: Novo Nordisk vs Eli Lilly
The pharmaceutical weight loss market heats up as Novo Nordisk's blockbuster drugs Wegovy and Ozempic confront serious competition from Eli Lilly's Mounjaro, reshaping diabetes and obesity treatment landscapes.
Trump's Secret Stance on Weight Loss Drugs Exposed
Explosive revelations emerge about Donald Trump's private stance on revolutionary weight loss drugs while new research highlights their massive economic potential.
Cholesterol drug cancer risk study reveals alarming findings
Groundbreaking research suggests widely prescribed cholesterol medication may have unexpected side effects, raising concerns among medical professionals and patients across the UK.
FDA warns of toxic cough syrups from China
US health authorities sound alarm after toxic chemical discovery in Chinese-manufactured cough syrups distributed across multiple states, prompting urgent product recalls.
Big Pharma's Tax Breaks: Calls for Transparency Grow
Pharmaceutical giants face mounting pressure to justify massive tax incentives amid concerns over NHS funding and pandemic-era profit surges. Westminster demands clarity on whether public investment delivers fair returns.
UK approves nasal spray for deadly allergic reactions
Britain's medical regulator greenlights a groundbreaking nasal spray that could prevent anaphylactic shock, offering new hope for those with severe allergies.
UK probes Pfizer and Novo Nordisk investments
The UK government launches a national security probe into major pharmaceutical investments by US-based Pfizer and Denmark's Novo Nordisk, raising concerns about foreign influence in Britain's vital healthcare sector.
61p-a-Day Tablets That Reduce Wrinkles
Discover the affordable anti-ageing tablets causing a stir in UK beauty circles. This dermatologist-approved formula promises visible results without breaking the bank.
Trump pressured FDA over autism drug approval
Exclusive investigation reveals Donald Trump's relentless pressure on FDA officials to fast-track leucovorin for autism treatment despite limited scientific evidence and expert warnings.
Blood Pressure Drug Recalled Over Contamination Fears
A critical safety alert has been issued for specific batches of Prazosin Hydrochloride tablets after potential contamination was discovered. Patients advised to check their medication immediately.
Urgent Recall: Cholesterol Drug Atorvastatin Pulled
Critical medication alert as thousands of packets of cholesterol-lowering drug Atorvastatin are recalled across Britain due to potential manufacturing defects posing serious health risks.
UK patients face treatment delays in pharma pricing crisis
A bitter pricing dispute between the UK government and pharmaceutical companies threatens to delay vital new medicines for NHS patients, with industry leaders warning of an escalating crisis.
FDA to lift UK blood donation ban
The US Food and Drug Administration proposes lifting restrictions on blood donations from British citizens, marking a significant policy shift for American healthcare safety protocols.
GSK chief warns UK drug pricing reforms threaten industry
Emma Walmsley warns that proposed NHS drug pricing reforms could devastate Britain's pharmaceutical industry and drive investment overseas in stark government warning.
GSK shares tumble nearly 10% on HIV drug trial results
Pharmaceutical giant GSK faces significant market pressure as its experimental HIV prevention drug shows mixed results in clinical trials, sending shares tumbling nearly 10%.
Thai herbal inhaler health warning over dangerous chemicals
Thailand's FDA issues urgent warning after laboratory tests reveal potentially harmful substances in widely-used herbal inhalers, prompting product recalls and consumer safety concerns.
Texas Lawsuit Demands Tylenol Pregnancy Warning
A landmark legal case in Texas could force Johnson & Johnson to add pregnancy warnings to Tylenol packaging, following claims linking the common painkiller to autism and ADHD in children.
NHS approves weight loss drug Mounjaro
The groundbreaking diabetes treatment Mounjaro receives NHS approval for weight management, offering new hope for millions struggling with obesity in the UK.
Mounjaro: UK Weight Loss Drug Revolution
The groundbreaking diabetes medication Mounjaro is transforming weight management across Britain, but availability and cost remain significant barriers for patients seeking its benefits.
Page 4 of 11